Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0
Sign in

X299bbf8b.babb.4be2.a190.5411dc005aae

· cohortA1

ec942ced-8492-572f-b4e3-936a2d4b15f4

Score in workbench →

Clinical attributes

From the source cohort, normalized into canonical keys plus the project's native columns.

cancer_type
cancer_type_detailed
subtype
cohortA1
subtype
cohortA1
age_years
64

GSVA pathway preview (0 Hallmark scores)

MeasuredDerivedReference

Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.

HTTPException: HTTP Error: HTTP GET error on 'https://pub-e056b053afc04eec88337b62541f3025.r2.dev/oncoscape/lung-landscapes/6/gsva.parquet' (HTTP 429 Too Many Requests)

Patient twins — nearest pathway neighbors

MeasuredDerived

10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.

10 twins match this tumor's tissue · 0 come from a different tissue of origin

#SampleCancer typeSubtypecos similarity
1SRR11296886
colon-landscapes@1
0.914
2TCGA-56-A4BX-01A-11R-A24H-07
lung-landscapes@6
cohortSQ20.911
3TCGA-AN-A0AR-01A-11R-A00Z-07
breast-umap@18
E0.896
4SRR8518365
breast-umap@18
E0.895
5SRR6013540
lung-landscapes@6
cohortSQ20.894
6MNG488
mng-umap@100
0.894
7dd75267f-824e-4ddc-9056-cdf0f500d39b
melanoma-umap@29
0.893
8ERR2208946
melanoma-umap@29
0.893
9SRR2932822
head-neck@1
0.889
1020040095.TNBC
breast-umap@18
E0.888

Per-pathway drug coverage

ModeledCalibratedDerived

For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.

0 of 15 elevated pathways have at least one drug that meaningfully reverses them.

Pathway (elevated)tumor scoreBest drugreversal magnitude
MYC_TARGETS_V20.440Idelalisib— uncovered
E2F_TARGETS0.320Inavolisib— uncovered
G2M_CHECKPOINT0.280Inavolisib— uncovered
MYC_TARGETS_V10.170Inavolisib— uncovered
KRAS_SIGNALING_DN0.120Remibrutinib— uncovered
MITOTIC_SPINDLE0.110Inavolisib— uncovered
DNA_REPAIR0.100Idelalisib— uncovered
APICAL_SURFACE0.080Temsirolimus— uncovered
SPERMATOGENESIS0.050Inavolisib— uncovered
ADIPOGENESIS0.040Inavolisib— uncovered
CHOLESTEROL_HOMEOSTASIS0.020Remibrutinib— uncovered
ESTROGEN_RESPONSE_EARLY0.020Inavolisib— uncovered
MYOGENESIS0.020Inavolisib— uncovered
APICAL_JUNCTION0.010Inavolisib— uncovered
WNT_BETA_CATENIN_SIGNALING0.010Inavolisib— uncovered